MedTrace Logo

Development of an Algorithm for Prediction of Onset of Hemodynamic Instability in Humans

NCT00581204 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 8

Last updated 2022-10-20

No results posted yet for this study

Summary

The purpose for this study is to measure the physiology of human undergoing a Lower Body Negative Pressure usea non-invasive low-power optical technique, near-infrared diffuse optical spectroscopy measurement and compare these measurement to standard monitoring procedures delineated in the Brooke Army Medical Center.

The Brooke Army Medical Center can use near-infrared diffuse optical spectroscopy to provide functional physiologic tissue and organ information without ionizing radiation and without withdrawing any blood, in a cost-effective and rapid manner. Monitoring for the onset of circulatory shock in a wounded soldier on the battlefield is typically performed by measurement of arterial blood pressure, arterial oxygen saturation, or simple auscultation of the pulse. Shock is typically recognized by non-specific signs and subjective symptoms such as cold clammy skin, pallor, weak thready pulse, unstable vital signs, and diminished mentation.

Conditions

  • Hemorrhagic Shock

Interventions

DEVICE

Near-Infrared Diffuse Optical Spectroscopy

Early predictor of hemorrhagic shock

Sponsors & Collaborators

  • Brooke Army Medical Center

    collaborator FED

  • Beckman Laser Institute University of California Irvine

    collaborator OTHER

  • University of California, Irvine

    lead OTHER

Principal Investigators

  • Matthew Brenner, M.D · Beckman Laser Institute University of California Irvine

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-12-31
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00581204 on ClinicalTrials.gov